|
Tyrosinase (146-156)??;SSDYVIPIGTY
|
|
|
|
Tyrosinase (206-214), T9206??;AFLPWHRLF
|
|
|
|
Tyrosinase (450-462)??;SYLQDSDPDSFQD
|
|
|
|
Tyrosinase (56–70)??;QNILLSNAPLGPQFP
|
|
|
|
Tyrosinase(243-251),core nonamer sequence??;KCDICTDEY
|
|
|
|
Tyrosinase (240-251)??;DAEKCDICTDEY
|
|
|
|
Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], 5-FAM labeled;5-FAM-KQAEAVTSPR
|
|
|
|
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK];KVEKIGEGTYGVVYK
|
TYROSINE KINASE PEPTIDE 1
|
|
|
Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], Biotinylated;Biotin-KQAEAVTSPR
|
|
|
|
Tyrosine Hydroxylase 24-33 [KQAEAVTSPR], 5-TMR labeled;5-TMR-KQAEAVTSPR
|
|
|
|
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], Bioyinylated;Biotin-KVEKIGEGTYGVVYK
|
|
|
|
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled;5-TMR-KVEKIGEGTYGVVYK
|
|
|
|
Tyrosine Hydroxylase 24-33 [KQAEAVTSPR];KQAEAVTSPR
|
|
|
|
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-FAM labeled;5-FAM-KVEKIGEGTYGVVYK
|
|
|
|
VSV(52-59)??;RGYGYQGL
|
|
|
|
Urotensin II, rat: [pGlu110]-Prepro-Urotensin II (110-123), rat;Pyr-HGTAPECFWKYCI(Disulfidebridge:8-13)
|
UROTENSIN II, RAT; [PYR110]-PREPRO-UROTENSIN II (110-123), RAT
|
|
|
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Amide, Phosphorylated;RRLIEDAE-pY-AARG-NH2
|
|
|
|
UOM9, PKC Substrate, phosphorylated;KRP-pS-QRHGSKY-NH2
|
UOM9, PKC SUBSTRATE, PHOSPHORYLATED
|
|
|
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Amide, Phosphorylated, Biotinylated;Biotin-RRLIEDAE-pY-AARG-NH2
|
|
|
|
VIP-Lys(Biotin), human, porcine, rat, FAM-labeled;FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILNK(Biotin)-NH2
|
|
|
|
Z-Arg-Gly-Phe-Phe-Leu-AFC;Z-RGFFL-AFC
|
Z-ARG-GLY-PHE-PHE-LEU-AFC
|
|
|
Z-Gly-Gly-Arg-AFC;Z-GGR-AFC
|
Z-GLY-GLY-ARG-AFC
|
|
|
Z-Val-Lys-Lys-Arg-AFC;Z-VKKR-AFC
|
Z-VAL-LYS-LYS-ARG-AFC
|
|
|
WAAG-3R;Abz-TEGEARGSVI-Dap(Dnp)-KK-NH2
|
生物活性肽WAAG-3R
|
|
|
VEGFR2/KDR Antagonist;ATWLPPR
|
ATWLPPR
|
|
|
α3β1 Integrin Peptide Fragment (325), amide;PRHRHMGAVFLLSQEAG-NH2
|
|
|
|
VIP, human, porcine, rat, FAM-labeled;FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
|
|
|
|
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Phosphorylated;RRLIEDAE-pY-AARG
|
|
|
|
Tyrosine Kinase Peptide 3 [RRLIEDAEYAARG], Biotinylated;Biotin-RRLIEDAEYAARG
|
BIOTIN-ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY-OH
|
|
|
WKYMVm-NH2;WKYMVm-NH2
|
WKYMVM-NH2
|
|
|
cyclo (Arg-Gly-Asp-d-Tyr-Lys(Biotin));c(RGDyK(Biotin));cyclo(RGDYK(Biotin))
|
CYCLO (ARG-GLY-ASP-D-TYR-LYS(BIOTIN));C(RGDYK(BIOTIN));CYCLO(RGDYK(BIOTIN))
|
|
|
CYCLO(ARG-GLY-ASP-D-Tyr-LYS(COCH2CH2SH))
|
CYCLO(ARG-GLY-ASP-D-TYR-LYS(COCH2CH2SH))
|
|
|
Fmoc-Glu(OtBu)-Ser{psi(Me,Me)pro}-OH
|
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
|
909115-33-9
|
|
Fmoc-Gln(Trt)-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1572725-72-4
|
|
Fmoc-Leu-Ser{psi(Me,Me)pro}-OH
|
FMOC-LEU-SER(PSI(ME,ME)PRO)-OH
|
|
|
Fmoc-Gly-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1262308-49-5
|
|
E-[cyclo(RGDfK)2
|
E-[CYCLO(RGDFK)2
|
|
|
Fmoc-Asp(OtBu)-Thr{psi(Me,Me)pro}-OH
|
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
|
920519-32-0
|
|
Fmoc-Ile-Ser{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸
|
1147996-34-6
|
|
Endotoxin Substrate;Boc-Leu-Gly-Arg-pNA
|
鲎试剂三肽
|
68223-96-1
|
|
FMOC-LYS(ME3)-OH HCL
|
N-芴甲氧羰基-N',N',N'-三甲基-L-赖氨酸盐酸盐
|
201004-29-7
|
|
CYCLO(ARG-GLY-ASP-D-Tyr-LYS(COCH2SH))
|
CYCLO(ARG-GLY-ASP-D-Tyr-LYS(巯基乙酸))
|
|
|
Fmoc-Val-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2,5-三甲基-4-恶唑烷羧酸
|
168216-05-5
|
|
Liraglutide /Liraglutide Acetate
|
利拉鲁肽/醋酸利拉鲁肽
|
204656-20-2
|
|
FMOC-LYS(ME)2-OH HCL
|
N-芴甲氧羰基-N',N'-二甲基-L-赖氨酸盐酸盐
|
252049-10-8
|
|
Fmoc-Glu(OtBu)-Thr{psi(Me,Me)pro}-OH
|
(4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸
|
1095952-22-9
|
|
Fmoc-Asn(Trt)-Thr{psi(Me,Me)pro}-OH
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-恶唑烷羧酸
|
957780-59-5
|
|
cyclo(Arg-Gly-Asp-D-Phe-Lys(Mpa))
|
CYCLO(ARG-GLY-ASP-D-PHE-LYS(MPA))
|
|
|
Fmoc-Asn(Trt)-Ser{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸
|
920519-33-1
|
|
Fmoc-Gln(Trt)-Ser{psi(Me,Me)pro}-OH
|
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
|
1821378-64-6
|
|
Fmoc-Ile-Thr{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸
|
339531-50-9
|
|
Fmoc-Asp(OtBu)-Ser{psi(Me,Me)pro}-OH
|
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
|
955048-92-7
|
|
α-Calcitonin Gene Related Peptide, α-CGRP, rat;SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7)
|
|
|
|
cyclo [Arg-Gly-Asp-d-Phe-Lys(Biotin)]
|
CYCLO [ARG-GLY-ASP-D-PHE-LYS(BIOTIN)]
|
|
|
Fmoc-Ala-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基恶唑烷-4-羧酸
|
252554-79-3
|
|
bursin trihydrochloride;LYS-HIS-GLY-NH2 80+%;L-Lysyl-L-histidylglycinaMide trihydrochloride
|
L-赖氨酰-L-组氨酰甘氨酰胺三盐酸盐
|
112898-17-6
|
|
linaclotide
|
利那洛肽
|
851199-59-2
|
|
CYCLO(ARG-GLY-ASP-D-Tyr-LYS(Mpa))
|
CYCLO(RGDyK(mpa));CYCLO(RGDyK(巯基丙酸))
|
|
|
Fmoc-Gly-Ser{psi(Me,Me)pro}-OH
|
FMOC-GLY-SER(PSI(ME,ME)PRO)-OH
|
1095952-22-9
|
|
BOC-GLY-OME
|
BOC-甘氨酸甲酯
|
31954-27-5
|
|
Dalargin,(D-Ala2)-Leu-Enkephalin-Arg;H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH
|
DALARGIN
|
81733-79-1
|
|
Tertiapin-Q
|
TERTIAPIN-Q
|
252198-49-5
|
|
cyclo (Arg-Ala-Asp-d-Phe-Cys)
|
CYCLO (ARG-ALA-ASP-D-PHE-CYS)
|
1055991-02-0
|
|
cyclo (Arg-Gly-Asp-d-Phe-Glu)
|
cyclo (Arg-Gly-Asp-d-Phe-Glu)
|
756500-22-8
|
|
cyclo (Arg-Gly-Asp-Phe-Glu)
|
CYCLO (RGDFE)
|
|
|
cyclo (Arg-Gly-Asp-D-Tyr-Cys)
|
CYCLO (RGDYC)
|
|
|
cyclo (Arg-Ala-Asp-Tyr-Cys)
|
CYCLO (RADYC)
|
|
|
γ-Bag Cell Peptide;RLRFD
|
Γ - BAG CELL PEPTIDE
|
|
|
TRP-2 coding region fragment??;LLPGGRPYR
|
|
|
|
cyclo (Arg-Gly-Asp-d-Phe-Cys)
|
CYCLO (ARG-GLY-ASP-D-PHE-CYS)
|
862772-11-0
|
|
α-MSH, amide;Ac-SYSMEHFRWGKPV-NH2
|
垂体中叶素
|
9061-59-0
|
|
Fmoc-Tyr(tBu)-Thr{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
920519-31-9
|
|
Fmoc-Leu-Thr{psi(Me,Me)pro}-OH
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
955048-89-2
|
|
ω-Conotoxin MVIIA;CKGKGAKCSRLMYDCCTGSCRSGKC-NH2(Disulfidebridge:1-16,8-20,and15-25)
|
醋酸齐考诺肽
|
107452-89-1
|
|
Fmoc-Trp(Boc)-Ser{psi(Me,Me)pro}-OH
|
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
|
908601-15-0
|
|
H-Glu[cyclo (Arg-Gly-Asp-d-Tyr-Lys)]2
|
H-GLU[CYCLO (ARG-GLY-ASP-D-TYR-LYS)]2
|
|
|
cyclo (Arg-Ala-Asp-Phe-Glu)
|
CYCLO (RADFE)
|
|
|
Fmoc-Tyr(tBu)-Ser{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸
|
878797-09-2
|
|
Fmoc-Phe-Ser{psi(Me,Me)pro}-OH
|
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2-二甲基-4-恶唑烷羧酸
|
878797-01-4
|
|
cyclo (Arg-Ala-Asp-Tyr-Lys)
|
cyclo (Arg-Ala-Asp-Tyr-Lys)
|
1193347-53-3
|
|
cyclo (Arg-Ala-Asp-Phe-Cys)
|
CYCLO (RADFC)
|
|
|
cyclo (Arg-Ala-Asp-Phe-Lys)
|
CYCLO (RADFK)
|
|
|
Fmoc-Ser(tBu)-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[(2S)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1266350-99-5
|
|
Fmoc-Lys(Boc)-Ser{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2,5-三甲基-4-恶唑烷羧酸
|
911838-56-7
|
|
β-catenin peptide, (βCATp)??NEW;RTYTYEKL
|
|
|
|
cyclo (Arg-Ala-Asp-d-Phe-Lys)
|
整合素配体多肽Cyclo(Arg-Ala-Asp-d-Phe-Lys）
|
756500-23-9
|
|
cyclo (Arg-Gly-Asp-Phe-Val)
|
CYCLO (RGDFV)
|
|
|
Fmoc-Ser(tBu)-Ser{psi(Me,Me)pro}-OH
|
D-丝氨酸伪二肽
|
1000164-43-1
|
|
Fmoc-Phe-Thr{psi(Me,Me)pro}-OH
|
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
1196703-48-6
|
|
cyclo (Arg-Ala-Asp-Phe-Val)
|
CYCLO (RADFV)
|
|
|
cyclo (Arg-Gly-Asp-Tyr-Glu)
|
CYCLO (RGDYE)
|
|
|
cyclo (Arg-Gly-Asp-Phe-Cys)
|
CYCLO (RGDFC)
|
|
|
cyclo (Arg-Gly-Asp-Tyr-Val)
|
CYCLO (RGDYV)
|
|
|
E-[C(RGDFK)2];H-GLU(CYCLO(ARG-GLY-ASP-D-PHE-LYS))2
|
E-[C(RGDFK)2]
|
|
|
β-Secretase Substrate 5, Swedish Double Mutation Sequence;[HiLyteFluor?488-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(QXL?520)-OH]
|
|
|
|
cyclo (Arg-Ala-Asp-d-Tyr-Cys)
|
CYCLO (ARG-ALA-ASP-D-TYR-CYS)
|
|
|
cyclo (Arg-Ala-Asp-Tyr-Val)
|
CYCLO (RADYV)
|
|
|
cyclo (Arg-Ala-Asp-Tyr-Glu)
|
CYCLO (RADYE)
|
|
|
cyclo (Arg-Gly-Asp-Tyr-Cys)
|
CYCLO (RGDYS)
|
|
|
SALUSIN-ALPHA (HUMAN)
|
SALUSIN-ALPHA (HUMAN)
|
624735-22-4
|